Cargando…

Secondary prevention following surgical revascularisation: continuing under-use of angiotensin-converting enzyme inhibitors

Detalles Bibliográficos
Autores principales:	Turley, A, Thornley, A, Roberts, A, Morley, R, Owens, W, de Belder, M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4095302/ http://dx.doi.org/10.1186/cc5409

Ejemplares similares

A novel score based on age and cardiac biomarkers predicts outcomes in severe sepsis and septic shock
por: Turley, A, et al.
Publicado: (2007)

Elevation of Troponin T in critically ill septic patients is common: but does it matter?
por: Thornley, A, et al.
Publicado: (2007)

Antifibrinolytic agents and angiotensin-converting enzyme inhibitors: the effect on postoperative renal dysfunction in cardiac surgery
por: Mouton, R, et al.
Publicado: (2007)

Angiotensin converting enzymes in patients with acute respiratory distress syndrome
por: Annoni, F, et al.
Publicado: (2015)

Cardiopulmonary resuscitation training: the need for continued education and training
por: Turley, A, et al.
Publicado: (2005)

Preoperative therapy with angiotensin-converting enzyme inhibitors in cardiac surgery patients: is there any impact on postoperative renal function?
por: Ampatzidou, F, et al.
Publicado: (2014)

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
por: Makdisse, MRP, et al.
Publicado: (2007)

Relationship between angiotensin-converting enzyme gene polymorphism (insertion/deletion) and the clinical condition of sepsis
por: Yildizdas, R
Publicado: (2008)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Reimbursement policy optimization for Angiotensin-converting enzyme (ACE) inhibitors in Bulgaria: Controlling expenditure without undermining access to treatment
por: Kazakov, Rossen M, et al.
Publicado: (2015)

Angiotensin-converting enzyme (ACE) insertion/deletion polymorphism and circulating ACE levels are not associated with outcome in septic critically ill patients
por: Tsangaris, I, et al.
Publicado: (2011)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Effect of angiotensin-converting enzyme gene I/D polymorphism and its expression on clinical outcome in acute respiratory distress syndrome
por: Tsangaris, I, et al.
Publicado: (2013)

Continuation of Angiotensin Converting Enzyme Inhibitors in Acute Heart Failure
por: AlHabeeb, Waleed, et al.
Publicado: (2021)

Elevated N-terminal pro-B-type natriuretic peptide levels and normal left ventricular systolic function: an echocardiographic study
por: Turley, A, et al.
Publicado: (2005)

N-terminal pro-B-type natriuretic peptide and the diagnosis of left ventricular systolic dysfunction: what is the optimal cut-off?
por: Turley, A, et al.
Publicado: (2005)

Coronary revascularisation in a patient with dextrocardia with situs inversus
por: Siddiqi, MS
Publicado: (2013)

Can N-terminal pro-B-type natriuretic peptide and troponin T predict ICU and hospital mortality in patients with septic shock?
por: Turley, A, et al.
Publicado: (2006)

Inpatient management of high-risk acute coronary syndrome patients in a district hospital setting
por: Turley, A, et al.
Publicado: (2006)

Small Bowel Angioedema Secondary to Angiotensin-Converting Enzyme Inhibitors
por: Inayat, Faisal, et al.
Publicado: (2016)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Cardiopulmonary exercise testing and NT-proBNP before major vascular surgery: do they correlate?
por: Turley, A, et al.
Publicado: (2006)

Preoperative assessment of patients undergoing abdominal aortic surgery: chronic kidney disease is almost always present
por: Turley, A, et al.
Publicado: (2007)

Transthoracic contrast echocardiography in the detection of patent foramen ovale
por: Turley, A, et al.
Publicado: (2006)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Coronary revascularisation in a pateint with dextrocardia with situs inversus – a case report
por: Siddiqi, MS
Publicado: (2013)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Angiotensin converting enzymes inhibitors or angiotensin receptor blockers should be continued in COVID-19 patients with hypertension
por: Tian, Ci, et al.
Publicado: (2021)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Investigation of the change in myocardial blood flow by perfusion CMR after revascularisation of chronically occluded coronary arteries
por: Zaman, Arshad, et al.
Publicado: (2011)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Effects of steroids and angiotensin converting enzyme inhibition on circumferential strain in boys with duchenne muscular dystrophy: a cross-sectional and longitudinal study utilizing cardiac magnetic resonance imaging
por: Williams, Katelyn, et al.
Publicado: (2011)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020)

Continuous electroencephalography in the surgical ICU
por: Wahl, A, et al.
Publicado: (2011)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ss1jq6rge7ei7engkdg9jk0ob4